Elevated circulating concentrations of the gut bacteria choline metabolite trimethylamine N‐
oxide (TMAO) were found in patients with type 2 diabetes mellitus (T2DM). However …

It has been suggested that trimethylamine N‐oxide (TMAO) is associated with increased risk
of diabetes and cardiovascular disease (CVD) morbidity and mortality. However, it is not …

The gut microbial metabolite trimethylamine N-oxide (TMAO) is increasingly regarded as a
novel risk factor for cardiovascular events and mortality. However, little is known about the …

Aims Gut microbiota-derived metabolite trimethylamine-N-oxide (TMAO) is emerging as a
new potentially important cause of increased cardiovascular risk. The purpose of this meta …

ABSTRACT Background Trimethylamine N-oxide (TMAO), a diet-derived, gut microbial-host
cometabolite, has been linked to cardiometabolic diseases. However, the relations remain …

Circulating trimethylamine N‐oxide (TMAO), a canonical metabolite from gut flora, has been
related to the risk of cardiovascular disorders. However, the association between circulating …

ABSTRACT Background Trimethylamine N-oxide (TMAO), a compound derived from diet
and metabolism by the gut microbiome, has been associated with several chronic diseases …

Diet has been considered a general health determinant for many years. Recent research
shows a connection between gut microbiota composition that is shaped by our diet and …

ABSTRACT Background Trimethylamine-N-oxide (TMAO) is a gut microbiota–derived
metabolite produced from dietary nutrients. Many studies have discovered that circulating …

The gut microbiota–derived metabolite trimethylamine N-oxide (TMAO) has been regarded
as one of the potent risk factors of cardiovascular events and diabetes. However, its …